Research News
Research News
-
What’s on the Treatment and Cure Horizon for HIV and Cancer?
-
The Promise of Immunotherapy to Cure HIV
A groundbreaking amfAR-funded HIV cure study using immunotherapy leads to potential breakthroughs in controlling the virus long-term.
-
Curing HIV—How Far Have We Come?
It can be hard to keep track of the various cases of HIV having been cured or controlled in the absence of antiretroviral therapy. amfAR has put together a helpful summary.
-
How T Cells Are Defining the Future of HIV Therapies and Beyond
Research into T cells holds the potential to make advances in HIV therapies and the treatment of conditions such as cancer and autoimmune diseases.
-
“Elite Controllers” Provide Clues for an HIV Cure Strategy
Researchers look to “elite controllers,” people with a natural ability to control HIV, for more answers about the role of immunity in an HIV cure.
-
amfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million
amfAR awards new research grants totaling $2.4 million for projects focused on a global HIV cure: scalable, accessible, and applicable for all.
-
The Importance of Sex in HIV Cure Strategies
A new amfAR-funded study led by Drs. Xu G. Yu and Mathias Lichterfeld suggests that sex differences influence the HIV reservoir, the main barrier to a cure.
-
How mRNA Could Help Create an HIV Vaccine
In a new study, researchers show potential of mRNA technology to provide a workaround for creating an effective immune response as part of an HIV vaccine.
-
amfAR Awards Boost Aspiring HIV Researchers
At a critical time for funding, amfAR awards four Mathilde Krim fellowships to early-career researchers studying innovative strategies to cure HIV.
-
Landmark Supreme Court Decision Protects Free Access to PrEP, Preventive Healthcare
The Court’s ruling upholds a key provision of the Affordable Care Act and represents an important victory for HIV prevention and health equity
-
Researchers Target and Awaken Dormant HIV in Groundbreaking Advance
Researchers use lipid nanoparticles—LNP X—to insert mRNA capable of targeting and awakening dormant HIV, the main barrier to a cure.
-
Refining Anti-HIV Gene Therapies
Using gene therapy, researchers modify stem cells to defend against and attack HIV in a multi-pronged approach to achieve lifelong remission or an HIV cure.
-
Learning from Post-Treatment Control
A new study on post-treatment control of HIV, co-authored by amfAR grantee Michael Peluso, suggests a therapeutic approach targeting the earliest timepoints of HIV and immune system interaction.
-
What’s New in HIV Science?
amfAR’s Director of Research Dr. Andrea Gramatica leads a roundtable discussion about HIV research advances with Drs. Marina Caskey, Brad Jones, and Guinevere Lee.
-
Demystifying mRNA
Research using mRNA technology has led to lifesaving vaccines and may lead to treatments for HIV and other diseases—its potential deserves support.